Membrane transporters in drug development
Open accessThe DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Abstract
Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs. This presents several key questions for drug development, including which transporters are clinically important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters. In addition, what criteria should trigger follow-up clinical studies, and which clinical studies should be conducted if needed. In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clinical studies on the currently recognized most important drug transporter interactions. The recommendations are generally intended to support clinical development and filing of a new drug application. Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clinical trial enrolment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metabolism and excretion properties of the drug molecule, and information required for drug labelling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To date, the human genome has been proven to have more than 400 membrane transporters, which are divided into two families: ATP binding cassette (ABC) and solute carrier (SLC) transporters [114].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Self-citationMammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
Cited by
Items 201–300 of 1,008
Gröer, C., Brück, S., Lai, Y., Paulick, A., Busemann, A., Heidecke, C.-D., Siegmund, W., & Oswald, S. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.07.031 · Cited by 146
Mutsaers, H. A. M., van den Heuvel, L. P., Ringens, L. H. J., Dankers, A. C. A., Rüssel, F. G. M., Wetzels, J. F. M., Hoenderop, J. G. J., & Masereeuw, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018438 · Cited by 146
Toxicokinetic Triage for Environmental Chemicals
Wambaugh, J. F., Wetmore, B. A., Pearce, R., Strope, C., Goldsmith, R., Sluka, J. P., Sedykh, A., Tropsha, A., Bosgra, S., Shah, I., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv118 · Cited by 144
Sonoda, Y., Newstead, S., Hu, N.-J., Alguel, Y., Nji, E., Beis, K., Yashiro, S., Lee, C., Leung, J., Cameron, A. D., et al. (2011) · Structure · doi:10.1016/j.str.2010.12.001 · Cited by 147
Self-citationWittwer, M. B., Zur, A. A., Khuri, N., Kido, Y., Kosaka, A., Zhang, X., Morrissey, K. M., Sali, A., Huang, Y., & Giacomini, K. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301302s · Cited by 142
Self-citationLee, C. A., O'Connor, M., Ritchie, T. K., Galetin, A., Cook, J., Ragueneau, I., Ellens, H. M., Feng, B., Taub, M. E., Paine, M. F., et al. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.062174 · Cited by 156
Self-citationKell, D. B., Dobson, P. D., Bilsland, E., & Oliver, S. G. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.11.008 · Cited by 154
Izumi, S., Nozaki, Y., Maeda, K., Komori, T., Takenaka, O., Kusuhara, H., & Sugiyama, Y. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.059105 · Cited by 143
Self-citationTherapeutic Protein–Drug Interactions and Implications for Drug Development
Huang, S.-M., Zhao, H., Lee, J.-I., Reynolds, K., Zhang, L., Temple, R., & Lesko, L. J. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.308 · Cited by 141
Self-citationDroździk, M., Busch, D., Łapczuk-Romańska, J., Müller, J., Ostrowski, M., Kurzawski, M., & Oswald, S. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1301 · Cited by 142
Tamai, I. (2013) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1816 · Cited by 141
“OCTs and OATs are categorized as transporters for cationic and anionic molecules (including xenobiotics), respectively; they can significantly affect drug disposition, and accordingly, they have to be considered as potential sites of drug-drug interaction during the clinical development of new drugs [1].”
BackgroundBioreactor technologies to support liver function in vitro
Ebrahimkhani, M. R., Neiman, J. A. S., Raredon, M. S. B., Hughes, D. J., & Griffith, L. G. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.011 · Cited by 135
Tweedie, D., Polli, J. W., Berglund, E. G., Huang, S. M., Zhang, L., Poirier, A., Chu, X., & Feng, B. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.77 · Cited by 139
Self-citationClinical Aspects of Transporter‐Mediated Drug–Drug Interactions
Gessner, A., König, J., & Fromm, M. F. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1360 · Cited by 139
Nakamura, K., Hirayama‐Kurogi, M., Ito, S., Kuno, T., Yoneyama, T., Obuchi, W., Terasaki, T., & Ohtsuki, S. (2016) · PROTEOMICS · doi:10.1002/pmic.201500433 · Cited by 136
Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms
Debotton, N., & Dahan, A. (2016) · Medicinal Research Reviews · doi:10.1002/med.21403 · Cited by 154
Impact of genetic variation in OATP transporters to drug disposition and response
Gong, I. Y., & Kim, R. B. (2013) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-12-rv-099 · Cited by 137
Self-citationLepist, E., Phan, T. K., Roy, A., Tong, L., Staiger, K. M., Murray, B. P., & Ray, A. S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01089-12 · Cited by 138
Schaefer, O., Ohtsuki, S., Kawakami, H., Inoue, T., Liehner, S., Saito, A., Sakamoto, A., Ishiguro, N., Matsumaru, T., Terasaki, T., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042275 · Cited by 152
Importance of Drug Pharmacokinetics at the Site of Action
Rizk, M., Zou, L., Savic, R., & Dooley, K. (2017) · Clinical and Translational Science · doi:10.1111/cts.12448 · Cited by 131
Nanoparticle drug delivery systems for synergistic delivery of tumor therapy
Chen, D., Liu, X., Lu, X., & Tian, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1111991 · Cited by 184
Clinical pharmacokinetics of second generation antisense oligonucleotides
Yu, R. Z., Grundy, J. S., & Geary, R. S. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.737320 · Cited by 135
Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban
Zhang, D., He, K., Herbst, J. J., Kolb, J. M., Shou, W. Z., Wang, L., Balimane, P. V., Han, Y., Gan, J., Frost, C. E., et al. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050260 · Cited by 135
Sudsakorn, S., Bahadduri, P. M., Fretland, J., & Lu, C. (2020) · Current Drug Metabolism · doi:10.2174/1389200221666200620210522 · Cited by 135
Hacker, K., Maas, R., Kornhuber, J., Fromm, M. F., & Zolk, O. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136451 · Cited by 135
A phosphotyrosine switch regulates organic cation transporters
Sprowl, J. A., Ong, S. S., Gibson, A. A., Hu, S., Du, G., Lin, W., Li, L., Bharill, S., Ness, R. A., Stecuła, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms10880 · Cited by 140
Nephrotoxicity and Kidney Transport Assessment on 3D Perfused Proximal Tubules
Vormann, M. K., Gijzen, L., Hutter, S., Boot, L., Nicolas, A., van den Heuvel, A., Vriend, J., Ng, C. P., Nieskens, T. T. G., van Duinen, V., et al. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0248-z · Cited by 131
A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies
Tan, H.-Y., Trier, S., Rahbek, U. L., Dufva, M., Kutter, J. P., & Andresen, T. L. (2018) · PLOS ONE · doi:10.1371/journal.pone.0197101 · Cited by 143
Comparison of minipig, dog, monkey and human drug metabolism and disposition
Dalgaard, L. (2015) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2014.12.005 · Cited by 132
Evers, R., Piquette‐Miller, M., Polli, J. W., Rüssel, F. G. M., Sprowl, J. A., Tohyama, K., Ware, J. A., de Wildt, S. N., Xie, W., & Brouwer, K. L. R. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1115 · Cited by 137
Self-citationVARIDT 1.0: variability of drug transporter database
Yin, J., Sun, W. C., Li, F., Hong, J., Li, X., Zhou, Y., Lu, Y., Liu, M., Zhang, X. Z., Chen, N., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz779 · Cited by 141
The ABCG family of membrane‐associated transporters: you don't have to be big to be mighty
Kerr, I. D., Haider, A. J., & Gelissen, I. C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01177.x · Cited by 147
Varma, M. V. S., Lai, Y., Feng, B., Litchfield, J., Goosen, T. C., & Bergman, A. J. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0792-7 · Cited by 131
Structure-Based Identification of OATP1B1/3 Inhibitors
Bruyn, T. D., van Westen, G. J. P., IJzerman, A. P., Stieger, B., de Witte, P. A. M., Augustijns, P., & Annaert, P. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.084152 · Cited by 131
Gomez-Zepeda, D., Taghi, M., Scherrmann, J.-M., Decleves, X., & Menet, M.-C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics12010020 · Cited by 124
Clinical Importance of OATP1B1 and OATP1B3 in DrugDrug Interactions
Shitara, Y. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rv-094 · Cited by 139
Arrayed lipid bilayer chambers allow single-molecule analysis of membrane transporter activity
Watanabe, R., Soga, N., Fujita, D., Tabata, K. V., Yamauchi, L., Kim, S. H., Asanuma, D., Kamiya, M., Urano, Y., Suga, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms5519 · Cited by 134
Schlessinger, A., Geier, E., Fan, H., Irwin, J. J., Shoichet, B. K., Giacomini, K. M., & Sali, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106030108 · Cited by 128
Self-citationKatt, M. E., Xu, Z. S., Gerecht, S., & Searson, P. C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152105 · Cited by 129
Bioengineered 3D Human Kidney Tissue, a Platform for the Determination of Nephrotoxicity
DesRochers, T. M., Suter, L., Roth, A., & Kaplan, D. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059219 · Cited by 128
Nieskens, T. T. G., Peters, J. G. P., Schreurs, M. J., Smits, N., Woestenenk, R., Jansen, K., van der Made, T. K., Röring, M., Hilgendorf, C., Wilmer, M. J., et al. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9871-8 · Cited by 124
Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein
Cho, H., & Yoon, I. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/736431 · Cited by 142
Targeting Intestinal Transporters for Optimizing Oral Drug Absorption
Varma, M. V. S., Ambler, C. M., Ullah, M., Rotter, C. J., Sun, H., Litchfield, J., Fenner, K. S., & El‐Kattan, A. F. (2010) · Current Drug Metabolism · doi:10.2174/138920010794328850 · Cited by 138
Blood-brain barrier, cytotoxic chemotherapies and glioblastoma
Dréan, A., Goldwirt, L., Verreault, M., Canney, M. S., Schmitt, C., Guehennec, J., Delattre, J., Carpentier, A. C., & Idbaïh, A. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1202761 · Cited by 130
Effect of Liver Disease on Hepatic Transporter Expression and Function
Thakkar, N., Slizgi, J. R., & Brouwer, K. L. R. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.053 · Cited by 128
Self-citationAl‐Majdoub, Z. M., Feteisi, H. A., Achour, B., Warwood, S., Neuhoff, S., Rostami‐Hodjegan, A., & Barber, J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01189 · Cited by 130
Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported Drugs
Yabe, Y., Galetin, A., & Houston, J. B. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040477 · Cited by 126
A widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase
Martinez, N. J., Asawa, R. R., Cyr, M. G., Zakharov, A., Urban, D. J., Roth, J. S., Wallgren, E., Klumpp-Thomas, C., Coussens, N. P., Rai, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27834-y · Cited by 118
Free energy of WALP23 dimer association in DMPC, DPPC, and DOPC bilayers
Castillo, N., Monticelli, L., Barnoud, J., & Tieleman, D. P. (2013) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2013.02.001 · Cited by 137
How do oral insecticidal compounds cross the insect midgut epithelium?
Denecke, S., Swevers, L., Douris, V., & VONTAS, J. G. (2018) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2018.10.005 · Cited by 142
Advanced approaches for improving bioavailability and controlled release of anthocyanins
Shen, Y., Zhang, N., Tian, J., Xin, G., Liu, L., Sun, X., & Li, B. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.031 · Cited by 132
de Lange, E. C. M. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-12 · Cited by 132
Distinct Conformational Spectrum of Homologous Multidrug ABC Transporters
Moeller, A., Lee, S. C., Tao, H., Speir, J. A., Chang, G. A., Urbatsch, I. L., Potter, C. S., Carragher, B. O., & Zhang, Q. (2015) · Structure · doi:10.1016/j.str.2014.12.013 · Cited by 129
Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells
Vée, M. L., Noel, G. L., Jouan, E., Stieger, B., & Fardel, O. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.07.003 · Cited by 120
Yoshida, K. J., Maeda, K., & Sugiyama, Y. (2012) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140309 · Cited by 133
Self-citationHarnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions
Gala, U., Miller, D. A., & Williams, R. O. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.188319 · Cited by 135
Effects of Chronic Renal Failure on Kidney Drug Transporters and Cytochrome P450 in Rats
Naud, J., Michaud, J., Beauchemin, S., Hébert, M., Roger, M., Lefrançois, S., Leblond, F. A., & Pichette, V. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.039115 · Cited by 135
Jabeen, I., Pleban, K., Rinner, U., Chiba, P., & Ecker, G. F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201705f · Cited by 135
Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa
Vakkalagadda, B. J., Frost, C. E., Byon, W., Boyd, R. A., Wang, J. J. J., Zhang, D., Yu, Z., Dias, C. S., Shenker, A., & LaCreta, F. P. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-015-0157-9 · Cited by 133
Animal models of toxicology testing: the role of pigs
Helke, K. L., & Swindle, M. M. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.739607 · Cited by 117
Bauer, M., Zeitlinger, M., Karch, R., Matzneller, P., Stanek, J., Jäger, W., Böhmdorfer, M., Wadsak, W., Mitterhauser, M., Bankstahl, J. P., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.217 · Cited by 119
Clinical Implications of P-Glycoprotein Modulation in Drug–Drug Interactions
Lund, M., Petersen, T. S., & Dalhoff, K. (2017) · Drugs · doi:10.1007/s40265-017-0729-x · Cited by 121
Arnst, K. E., Wang, Y., Hwang, D., Xue, Y., Costello, T., Hamilton, D. J., Chen, Q., Yang, J., Park, F., Dalton, J. T., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0577 · Cited by 121
Liu, J., Ye, Z., Xiang, M., Chang, B., Cui, J., Ji, T., Zhao, L., Li, Q., Deng, Y., Xu, L., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119475 · Cited by 121
Yang, K., Köck, K., Sedykh, A., Tropsha, A., & Brouwer, K. L. R. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23584 · Cited by 114
Self-citationA Perspective on Efflux Transport Proteins in the Liver
Köck, K., & Brouwer, K. L. R. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.79 · Cited by 112
Self-citationDrug discovery in the next decade: innovation needed ASAP
Bennani, Y. L. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.004 · Cited by 132
Intrinsically disordered proteins and novel strategies for drug discovery
Uversky, V. N. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.686489 · Cited by 115
Miners, J. O., Yang, X., Knights, K., & Zhang, L. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.757 · Cited by 130
Self-citationKarlgren, M., Ahlin, G., Bergström, C. A. S., Svensson, R., Palm, J., & Artursson, P. (2012) · Pharmaceutical Research · doi:10.1007/s11095-011-0564-9 · Cited by 119
Nicklisch, S. C. T., Rees, S. D., McGrath, A. P., Gökirmak, T., Bonito, L. T., Vermeer, L. M. M., Cregger, C., Loewen, G. J., Sandin, S. A., Chang, G. A., et al. (2016) · Science Advances · doi:10.1126/sciadv.1600001 · Cited by 118
Foti, R., & Dalvie, D. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.071753 · Cited by 120
Deuterium‐ und tritiummarkierte Verbindungen: Anwendungen in den modernen Biowissenschaften
Atzrodt, J., Derdau, V., Kerr, W. J., & Reid, M. (2017) · Angewandte Chemie · doi:10.1002/ange.201704146 · Cited by 118
The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates
Järvinen, E., Deng, F., Kiander, W., Sinokki, A., Kidron, H., & Sjöstedt, N. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.802539 · Cited by 111
Polyamines and membrane transporters
Al-Ali, A. A. A., & WALLACE, H. M. (2013) · Amino Acids · doi:10.1007/s00726-013-1553-6 · Cited by 118
Martovetsky, G., Tee, J. B., & Nigám, S. K. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088229 · Cited by 129
Prasad, B., Lai, Y., Lin, Y. S., & Unadkat, J. D. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23436 · Cited by 117
Chaccour, C., Hammann, F., & Rabinovich, N. R. (2017) · Malaria Journal · doi:10.1186/s12936-017-1801-4 · Cited by 132
Verapamil Targets Membrane Energetics in Mycobacterium tuberculosis
Chen, C., Gardete, S., Jansen, R. S., Shetty, A., Dick, T., Rhee, K. Y., & Dartois, V. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02107-17 · Cited by 129
Microengineered Liver Tissues for Drug Testing
Khetani, S. R., Berger, D. R., Ballinger, K. R., Davidson, M. D., Lin, C., & Ware, B. R. (2015) · SLAS Technology · doi:10.1177/2211068214566939 · Cited by 116
“Both uptake and efflux transporters, distributed over many organs, are now recognized as major contributors to overall drug disposition in the body.(163,164) Thus, a variety of in vitro models have been developed to assess transporter contributions.”
BackgroundA2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability
Kim, D.-G., & Bynoe, M. S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8879-2 · Cited by 111
The physiological role of drug transporters
Liang, Y., Li, S., & Chen, L. (2015) · Protein & Cell · doi:10.1007/s13238-015-0148-2 · Cited by 130
Optimized Approaches for Quantification of Drug Transporters in Tissues and Cells by MRM Proteomics
Prasad, B., & Unadkat, J. D. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9602-y · Cited by 126
Gao, S., Siddiqui, N., Etim, I., Du, T., Zhang, Y., & Liang, D. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112080 · Cited by 116
Bikádi, Z., Hazai, I., Malik, D., Jemnitz, K., Veres, Z., Hári, P., Ni, Z., Loo, T. W., Clarke, D. M., Hazai, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025815 · Cited by 117
Štaud, F., Červený, L., & Čečková, M. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.716847 · Cited by 126
Ménochet, K., Kenworthy, K. E., Houston, J. B., & Galetin, A. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.046193 · Cited by 123
Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites
Patel, M., Taskar, K. S., & Zamek‐Gliszczynski, M. J. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.671 · Cited by 123
Self-citationPatel, D., Bertz, R., Ren, S., Boulton, D. W., & Någård, M. B. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00844-3 · Cited by 116
Li, N., Wang, D., Sui, Z., Qi, X., Ji, L., Wang, X., & Yang, L. (2013) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0463 · Cited by 114
Expression, regulation and function of intestinal drug transporters: an update
Müller, J., Keiser, M., Droździk, M., & Oswald, S. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0259 · Cited by 114
Membrane Transporters in Drug Development
Keogh, J. P. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-398339-8.00001-x · Cited by 121
Emerging Kidney Models to Investigate Metabolism, Transport, and Toxicity of Drugs and Xenobiotics
Bajaj, P., Chowdhury, S. K., Yucha, R. W., Kelly, E. J., & Xiao, G. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.082958 · Cited by 123
Anticancer Drug-Induced Acute Kidney Injury
Izzedine, H., & Perazella, M. A. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.02.008 · Cited by 118
Banerjee, S., Arnst, K. E., Wang, Y., Kumar, G., Deng, S., Yang, L., Li, G., Yang, J., White, S. W., Li, W., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01858 · Cited by 114
Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin
Katsube, T., ECHOLS, R. M., & Wajima, T. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz828 · Cited by 114
Cressman, A. M., Petrović, V., & Piquette‐Miller, M. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.66 · Cited by 134
Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3)
Liang, X., Chien, H.-C., Yee, S. W., Giacomini, M. M., Chen, E. C., Piao, M., Hao, J., Twelves, J., Lepist, E.-I., Ray, A. S., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00501 · Cited by 109
Self-citationElmeliegy, M. A., Carcaboso, A. M., Tagen, M., Bai, F., & Stewart, C. F. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1934 · Cited by 108
OCTN Cation Transporters in Health and Disease: Role as Drug Targets and Assay Development
Pochini, L., Scalise, M., Galluccio, M., & Indiveri, C. (2013) · SLAS Discovery · doi:10.1177/1087057113493006 · Cited by 108
Metadata
- Authors
- The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K. M., Hoffmaster, K. A., Ishikawa, T., Keppler, D., Kim, R. B., Lee, C. A., Niemi, M., Polli, J. W., Sugiyama, Y., Swaan, P. W., Ware, J. A., Wright, S. H., Wah Yee, S., Zamek-Gliszczynski, M. J., & Zhang, L.
- Affiliations
- University of California, San Francisco (US)
- United States Food and Drug Administration (US)
- Boehringer Ingelheim (United States) (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Abbott (United States) (US)
- Eli Lilly (United States) (US)
- Novartis (United States) (US)
- RIKEN (JP)
- German Cancer Research Center (DE)
- Western University (CA)
- GlaxoSmithKline (United Kingdom) (GB)
- Genentech (US)
- University of Maryland, Baltimore (US)
- University of Arizona (US)
- ORCID
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-03
- Volume
- 9
- Issue
- 3
- Pages
- 215-236
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3326076
- OpenAlex
- W2079197876
- Cited by
- 3,340
- References
- 225
- Citations by year
- 2026: 105 · 2025: 118 · 2024: 153 · 2023: 175 · 2022: 180 · 2021: 237 · 2020: 187 · 2019: 219 · 2018: 234 · 2017: 216 · 2016: 242 · 2015: 233 · 2014: 248 · 2013: 316 · 2012: 254
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- National Institutes of Health (GM61390)
- U.S. Food and Drug Administration
- National Institute of General Medical Sciences (GM61390, R01GM041935, U19GM061390, U01GM061390)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080801, R01DK061425)
- National Institute of Environmental Health Sciences (P30ES006694)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- membrane transporters, drug transporters, drug-drug interactions, pharmacokinetics, drug absorption, drug disposition, drug development, drug safety and efficacy, drug labeling
- MeSH terms
- Animals, Computer Simulation, Decision Trees, Drug Interactions, Drug Evaluation, Preclinical, Humans, Drug Approval, Mice, Knockout, Membrane Transport Proteins, Mice, Prescription Drugs, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.